Optimal Timing of Measles Vaccination in High-Risk Areas: Insights from MR-1 Administration and Subsequent Dosing Efficacy
Vol. 64 No. 3 (2023), Editorial
Vol. 64 No. 3 (2023)

Optimal Timing of Measles Vaccination in High-Risk Areas: Insights from MR-1 Administration and Subsequent Dosing Efficacy: Optimal Timing of Measles Vaccination in High-Risk Areas

Editorial
https://doi.org/10.15167/2421-4248/jpmh2023.64.3.3075
Published 2023-11-10
Sinu Jose
PGIMER, CHANDIGARH, INDIA
pdf

Keywords

MR vaccine, outbreak response, outbreak investigation, measles prevention, case report.

Abstract

Not applicable, letters to editor or editorial 

https://doi.org/10.15167/2421-4248/jpmh2023.64.3.3075
pdf

References

World health organization. Measles vaccines: WHO position paper-April 2017 [Internet]. Geneva; 2017. Available from https://www.who.int/publications/i/item/who-wer9217-205-227

Center for disease control and prevention. Global measles outbreak [Internet]. United Nations; 2022 [cited 2023 Apr 20]. Available from https://www.cdc.gov/globalhealth/measles/data/global-measles-outbreaks.html

World health organization. Measles and rubella [Internet]. Geneva; 2022 [Cited 2023 April 10]. Available from https://www.who.int/india/health-topics/measles.

Singh J, Sharma RS, Verghese T. Measles mortality in India: a review of community based studies. J Commun Dis. 1994 Dec;26(4):203-14. Available from https://pubmed.ncbi.nlm.nih.gov/7759802/

Patel MK, Orenstein WA. Classification of global measles cases in 2013-17 as due to policy or vaccination failure: a retrospective review of global surveillance data. Lancet Glob Health. 2019 Mar;7(3):e313-e320. doi: 10.1016/S2214-109X(18)30492-3

Vitek CR, Aduddell M, Brinton MJ, Hoffman RE, Redd SC. Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine. Pediatr Infect Dis J. 1999 Jul;18(7):620-3. doi: 10.1097/00006454-199907000-00010

Nic Lochlainn LM, de Gier B, van der Maas N: Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis. Lancet Infect Dis. 2019, 19:1235-1245. 10.1016/S1473-3099(19)30395-0